Patent ID: 8614235

Claim:
A method for treating a patient suffering from age-related macular degeneration or diabetic retinopathy comprising: (a) diagnosing age-related macular degeneration or diabetic retinopathy in a patient; and (b) ocularly administering to said patient a sterile, aqueous suspension formulation free of organic solvents comprising: about 0.1 to about 2% w/v of suspended solid microparticulates of CAT (5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) in free base form; 0.051% w/v of Monobasic Sodium Phosphate Dihydrate; 0.5% w/v of Dibasic Sodium Phosphate Dodecahydrate; 0.05 to 0.4% w/v of Tyloxapol; and 0.76% w/v of Sodium Chloride; wherein the aqueous suspension formulation is at a pH from about 5.0 to 8.4, and wherein the ocular administration is by intravitreal injection.